Amprion raises $6M for neurodegenerative disease diagnostics
Advanced diagnostics company Amprion reports that it has raised $6 million out of a planned $15 million Series B financing round. The funding will help the company promote diagnostic testing for neurodegenerative diseases like Parkinson’s, Alzheimer’s and Lewy body dementia. Amprion’s flagship…
Read More